Dedicated to NPs, PAs and rheumatologists who diagnose and treat arthritis and other musculoskeletal conditions.
Search:

key topics



navigation

Ankylosing Spondylitis

Sometimes referred to as rheumatoid spondylitis, ankylosing spondylitis is a chronic, inflammatory disease that causes pain and progressive stiffness. The condition targets the costovertebral, sacroiliac and apophyseal joints, including surrounding tissues. The condition is reportedly more frequent among men between 20 to 40 years of age. Primary treatment modalities include pharmacotherapy, physical therapy and exercise.
How To Manage Ankylosing Spondylitis
Given the serious nature of ankylosing spondylitis, these authors review common signs and symptoms, offer pertinent diagnostic insights and discuss the available treatment options for managing this condition.


Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis
Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis News & Trends: Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis - By Anthony Leone, Associate Editor Results of a five-year study showed that the majority of patients taking infliximab (Remicade, Centocor) for ankylosing spondylitis safely tolerated the drug and a third of the patients had complete remission without any major side effects. Two recent studies show promising findings in the use of anti-TNF drugs to ...


September/October 2005
Celecoxib Gains New Indication For Ankylosing Spondylitis Ankylosing spondylitis, a form of chronic inflammation of the spine and sacroiliac joints, affects over 400,000 people in the United States. Dr. Barkhuizen cites a pivotal 12-week clinical trial in which patients with ankylosing spondylitis experienced no peptic ulcers when treated with celecoxib. Celecoxib is contraindicated in patients with a known sulfonamide allergy, according to Dr. Barkhuizen, an Associate Professor of Medicine...


When A Patient Presents With Low Back Pain
The physical examination of the spine reveals tenderness over the lumbosacral spine and the sacroiliac joints. Radiographs of the lumbosacral spine and sacroiliac joints reveal squaring of the vertebrae and subchorial erosion of the sacroiliac joints. The physical examination of patients with this condition may reveal psoriatic nail disease and distal interphalangeal involvment, asymmetric oligoarthropahy symmetirc polyarthropathy, arthritis mutilans and psoritatic spondylitis.


When A Child Presents With Progressive Low Back Pain
Further history reveals the patient also had progressive left knee pain and swelling several months before his complaints of low back pain. These symptoms include joint and periarticular pain without objective findings, chronic or recurrent arthritis of the large joints, and chronic synovitis. Symptoms may not evolve until weeks or months after the acute illness, and the symptoms may include severe polyarticular involvement.


RA Study: Etanercept Shows Sustained Efficacy For Up To Nine Years
In assessing 77 patients with early RA and 280 patients with longstanding RA who completed eight years of treatment with etanercept, researchers found that 75 percent of patients with early RA and 76 percent of those with longstanding RA achieved an ACR 20 score. A.L. Study Says: Abatacept Offers Sustained Benefits In RA Patients After two years of receiving treatment with abatacept, patients with RA maintained significant improvements, according to study findings that were presented ...


What Does The Future Hold For Etoricoxib?
Two studies published separately in The Lancet in recent months discussed results from the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study, which involved 34,701 patients with OA or RA. Combination Therapy For Early RA: What One Study Reveals By Aaron Becker, Associate Editor When it comes to early rheumatoid arthritis (RA), initial combination therapy provides ? While the study suggests that cognitive behavioral therapy can be effective for patients with depression...


When Sleep Disorders Affect Rheumatology Patients
Given the frequent link between sleep disorders and associated rheumatologic conditions, and the possible need for diagnostic referrals, this author discusses some of the common findings as well as helpful diagnostic tests that can be preformed at sleep laboratories.


What You Should Know About Psoriatic Arthritis
Given that the diagnosis of psoriatic arthritis is often missed and the potential impact of delayed treatment, this author reviews the pathophysiology and classifications of this condition. She also offers pertinent treatment pointers and insightful case studies.


July/August 2005
July/August 2005 News & Trends: July/August 2005 Prescribing Study Shows Similarities Between PAs, NPs And Physicians An intriguing study that evaluated prescribing practices in primary care over a six-year period found a great deal of common ground between physician assistants (PAs), nurse practitioners (NPs) and physicians. Nurse practitioners saw patients with acute problems nearly 45 percent of the time whereas PAs saw these patients 30.1 percent of the time and physicians saw these ...






© 2007 HMP Communications | All Rights Reserved
83 General Warren Blvd | Suite 100 | Malvern, PA 19355
Contact Us | Reprints/Permissions


July 19, 2008

Emerging Concepts In Treating Rheumatoid Arthritis

A complimentary CME Webcast Event

To register for this Web Archive program, click on Complimentary CME Webcast Event


This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine physicians who treat patients with rheumatoid arthritis (RA).


Panelists/Lectures

"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.

"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle

"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.

This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).


Current Insights On Combination Therapy For Rheumatoid Arthritis

A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)

To register for this Webcast program, click on Complimentary CME Webcast


This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.

Agenda And Faculty

“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center

“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center

“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas

This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).


A Guide To Viscosupplementation For Osteoarthritis Knee Pain

A complimentary CME Web Archive Event

To register for this Web Archive program, click on Complimentary CME Web Archive Event


This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.

Agenda And Faculty

“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC

“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD

“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY

This activity is supported by an educational grant from Genzyme.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).



A Complimentary CME Webcast Event

A Guide To Infusion Therapy For Patients With Rheumatoid Arthritis

A Complimentary, On-Demand CME Webcast

To register for this Webcast program, click on Complimentary CME Webcast Event


This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.

AGENDA and FACULTY

"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology

"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine

"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.

This activity is supported by an educational grant from Bristol-Myers Squibb.

The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).